A sweeping review of 67 trials has cast doubt on the use of ketamine and similar NMDA receptor antagonists for chronic pain relief. While ketamine is frequently prescribed off-label for conditions …
https://www.sciencedaily.com/releases/2025/08/250818102944.htm

